Skip to main content
Top
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Myasthenia Gravis | Research

Taste disorders and alopecia in myasthenia gravis

Authors: Akiyuki Uzawa, Shigeaki Suzuki, Satoshi Kuwabara, Hiroyuki Akamine, Yosuke Onishi, Manato Yasuda, Yukiko Ozawa, Naoki Kawaguchi, Tomoya Kubota, Masanori P. Takahashi, Yasushi Suzuki, Genya Watanabe, Takashi Kimura, Takamichi Sugimoto, Makoto Samukawa, Naoya Minami, Masayuki Masuda, Shingo Konno, Yuriko Nagane, Kimiaki Utsugisawa

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Non-motor symptoms in myasthenia gravis (MG) are rarely confirmed. Although there are some small cohort studies, a large-systemic survey has not yet been performed.

Methods

We investigated the incidence and clinical characteristics of patients with MG who had taste disorders and alopecia using data of 1710 patients with MG enrolled in the Japan MG Registry 2021.

Results

Among them, 104 (6.1%) out of 1692 patients and 138 (8.2%) out of 1688 patients had histories of taste disorders and alopecia, respectively. Among the patients with MG, taste disorders were significantly more common in women, those with severe symptoms, refractory MG, or thymoma-associated MG, and were less common in those with ocular MG. The taste disorders often occurred after the onset of MG and often responded to MG treatments. Alopecia was more common in MG patients with a history of bulbar palsy and thymoma, and it often occurred before the onset of MG and sometimes responded to MG treatments. Multivariate logistic regression analysis revealed taste disturbance was associated with worst quantitative MG score and thymoma-associated MG; and alopecia was associated with thymoma-associated MG.

Conclusion

Clinicians should be aware of the non-motor symptoms in MG, especially in patients with severe myasthenic symptoms and thymoma-associated MG.
Literature
1.
go back to reference Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21:176–88.CrossRefPubMed Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21:176–88.CrossRefPubMed
2.
go back to reference Suzuki S, Utsugisawa K, Suzuki N. Overlooked non-motor symptoms in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2013;84:989–94.CrossRefPubMed Suzuki S, Utsugisawa K, Suzuki N. Overlooked non-motor symptoms in myasthenia gravis. J Neurol Neurosurg Psychiatry. 2013;84:989–94.CrossRefPubMed
3.
go back to reference Kabasawa C, Shimizu Y, Suzuki S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Utsumi H, Fujihara K, Suzuki N, Uchiyama S. Taste disorders in myasthenia gravis: a multicenter cooperative study. Eur J Neurol. 2013;20:205–7.CrossRefPubMed Kabasawa C, Shimizu Y, Suzuki S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Utsumi H, Fujihara K, Suzuki N, Uchiyama S. Taste disorders in myasthenia gravis: a multicenter cooperative study. Eur J Neurol. 2013;20:205–7.CrossRefPubMed
4.
go back to reference Suzuki S, Shimoda M, Kawamura M, Sato H, Nogawa S, Tanaka K, Suzuki N, Kuwana M. Myasthenia gravis accompanied by Alopecia Areata: clinical and immunogenetic aspects. Eur J Neurol. 2005;12:566–70.CrossRefPubMed Suzuki S, Shimoda M, Kawamura M, Sato H, Nogawa S, Tanaka K, Suzuki N, Kuwana M. Myasthenia gravis accompanied by Alopecia Areata: clinical and immunogenetic aspects. Eur J Neurol. 2005;12:566–70.CrossRefPubMed
5.
go back to reference Kubota A, Komiyama A, Hasegawa O. Myasthenia gravis and alopecia areata. Neurology. 1997;48:774–5.CrossRefPubMed Kubota A, Komiyama A, Hasegawa O. Myasthenia gravis and alopecia areata. Neurology. 1997;48:774–5.CrossRefPubMed
6.
go back to reference Suzuki S, Masuda M, Uzawa A, Nagane Y, Konno S, Suzuki Y, et al. Japan MG registry: chronological surveys over 10 years. Clin Exp Neuroimmunol. 2023;14:5–12.CrossRef Suzuki S, Masuda M, Uzawa A, Nagane Y, Konno S, Suzuki Y, et al. Japan MG registry: chronological surveys over 10 years. Clin Exp Neuroimmunol. 2023;14:5–12.CrossRef
7.
go back to reference Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 2023;94:467–73.CrossRefPubMed Uzawa A, Suzuki S, Kuwabara S, Akamine H, Onishi Y, Yasuda M, Ozawa Y, Kawaguchi N, Kubota T, Takahashi MP, Suzuki Y, Watanabe G, Kimura T, Sugimoto T, Samukawa M, Minami N, Masuda M, Konno S, Nagane Y, Utsugisawa K. Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis. J Neurol Neurosurg Psychiatry. 2023;94:467–73.CrossRefPubMed
8.
go back to reference Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa A, Suzuki S. The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome. Clin Exp Neuroimmunol. 2023;14:19–27.CrossRef Murai H, Utsugisawa K, Motomura M, Imai T, Uzawa A, Suzuki S. The Japanese clinical guidelines 2022 for myasthenia gravis and Lambert–Eaton myasthenic syndrome. Clin Exp Neuroimmunol. 2023;14:19–27.CrossRef
9.
go back to reference Hoffman HJ, Cruickshanks KJ, Davis B. Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci. 2009;1170:514–30.CrossRefPubMedPubMedCentral Hoffman HJ, Cruickshanks KJ, Davis B. Perspectives on population-based epidemiological studies of olfactory and taste impairment. Ann N Y Acad Sci. 2009;1170:514–30.CrossRefPubMedPubMedCentral
10.
go back to reference Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;546:116–21.CrossRef Tomita H, Yoshikawa T. Drug-related taste disturbances. Acta Otolaryngol Suppl. 2002;546:116–21.CrossRef
12.
go back to reference Aranishi T, Ito T, Fukuyama M, Isaka Y, Mackie DS, King-Concialdi K, Senglaub SS, Jaffe DH, Shimomura Y, Ohyama M. Prevalence of Alopecia Areata in Japan: estimates from a nationally representative sample. J Dermatol. 2023;50:26–36.CrossRefPubMed Aranishi T, Ito T, Fukuyama M, Isaka Y, Mackie DS, King-Concialdi K, Senglaub SS, Jaffe DH, Shimomura Y, Ohyama M. Prevalence of Alopecia Areata in Japan: estimates from a nationally representative sample. J Dermatol. 2023;50:26–36.CrossRefPubMed
13.
14.
go back to reference Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L, Fattorossi A. Paraneoplastic diseases associated with thymoma. J Neurol. 2007;254:756–62.CrossRefPubMed Evoli A, Minicuci GM, Vitaliani R, Battaglia A, Della Marca G, Lauriola L, Fattorossi A. Paraneoplastic diseases associated with thymoma. J Neurol. 2007;254:756–62.CrossRefPubMed
Metadata
Title
Taste disorders and alopecia in myasthenia gravis
Authors
Akiyuki Uzawa
Shigeaki Suzuki
Satoshi Kuwabara
Hiroyuki Akamine
Yosuke Onishi
Manato Yasuda
Yukiko Ozawa
Naoki Kawaguchi
Tomoya Kubota
Masanori P. Takahashi
Yasushi Suzuki
Genya Watanabe
Takashi Kimura
Takamichi Sugimoto
Makoto Samukawa
Naoya Minami
Masayuki Masuda
Shingo Konno
Yuriko Nagane
Kimiaki Utsugisawa
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03644-w

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue